KINETICS OF THE INHIBITION OF HUMAN-LEUKOCYTE ELASTASE BY ELAFIN, A 6-KILODALTON ELASTASE-SPECIFIC INHIBITOR FROM HUMAN SKIN

被引:41
|
作者
YING, QL
SIMON, SR
机构
[1] SUNY STONY BROOK,DEPT BIOCHEM,STONY BROOK,NY 11794
[2] SUNY STONY BROOK,DEPT PATHOL,STONY BROOK,NY 11794
关键词
D O I
10.1021/bi00058a021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated the kinetics of inhibition of human leukocyte elastase by elafin, a small protein originally isolated from human skin. A single inhibitor molecule was found to bind to a single site on the protease, blocking the reactive serine at the enzyme's catalytic center. Association of the enzyme with the inhibitor proceeds via a single bimolecular process, with a second-order rate constant of 3.6 X 10(6) M-1 s-1 at pH 8.0 and 25-degrees-C. Dissociation of the enzyme-inhibitor complex regenerates fully active enzyme with a first-order rate constant of 6.0 x 10(-4) s-1. The species of elafin which is released from the complex simultaneously with the enzyme was estimated to be at least 99.8% active, with association and dissociation kinetics identical to preparations of the inhibitor which had never been exposed to the enzyme. K(i), the equilibrium dissociation constant of the enzyme-inhibitor complex, decreases from 6.7 x 10(-9) to 2.0 x 10(-10) M as the pH is increased from 5.4 to 9.0. The effect of pH on the association rate constant reveals that the reaction rate is dependent on the concentration of the unprotonated form of a group with pK(a) of 6.8, which we have assigned to the histidine which forms part of the catalytic triad in the enzyme's active site. On the basis of these findings, we conclude that elafin is a potent, substratelike, but fully reversible inhibitor of human leukocyte elastase.
引用
收藏
页码:1866 / 1874
页数:9
相关论文
共 50 条
  • [31] Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters
    J-M Sallenave
    Z Xing
    AJ Simpson
    FL Graham
    J Gauldie
    Gene Therapy, 1998, 5 : 352 - 360
  • [32] CHARACTERIZATION AND GENE SEQUENCE OF THE PRECURSOR OF ELAFIN, AN ELASTASE-SPECIFIC INHIBITOR IN BRONCHIAL-SECRETIONS
    SALLENAVE, JM
    SILVA, A
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 8 (04) : 439 - 445
  • [33] Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters
    Sallenave, JM
    Xing, Z
    Simpson, AJ
    Graham, FL
    Gauldie, J
    GENE THERAPY, 1998, 5 (03) : 352 - 360
  • [34] Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and Farmer's lung
    Tremblay, GM
    Sallenave, JM
    IsraelAssayag, E
    Cormier, Y
    Gauldie, J
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) : 1092 - 1098
  • [35] STRUCTURE DIRECTED ENZYME-INHIBITOR DESIGN - HUMAN-LEUKOCYTE ELASTASE
    UNDERWOOD, DJ
    DOHERTY, J
    MACCOSS, M
    NAVIA, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 172 - MEDI
  • [36] A NEW CLASS OF INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE
    HASSALL, CH
    JOHNSON, WH
    KENNEDY, AJ
    ROBERTS, NA
    FEBS LETTERS, 1985, 183 (02) : 201 - 205
  • [37] UNIQUE CLEAVAGE OF FIBRINOGEN BY HUMAN-LEUKOCYTE ELASTASE
    WEITZ, J
    CROWLEY, K
    LANDMAN, S
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 39 - 39
  • [38] A SPECIFIC RADIOIMMUNOASSAY FOR PEPTIDES DERIVED FROM HUMAN-LEUKOCYTE ELASTASE DEGRADATION OF HUMAN FIBRIN(OGEN)
    SALDEEN, TGP
    WALLIN, R
    CIRCULATION, 1987, 76 (04) : 339 - 339
  • [39] MEASUREMENT OF FREE HUMAN-LEUKOCYTE ELASTASE AND HUMAN-LEUKOCYTE ELASTASE ALPHA-1 PROTEINASE-INHIBITOR COMPLEXES BY AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY
    KRAMER, MD
    MULLERBARDORFF, M
    SIMON, MM
    TILGEN, W
    SCHICKEL, E
    PETZOLDT, D
    JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 131 (01) : 41 - 48
  • [40] REVERSIBLE, SLOW, TIGHT-BINDING INHIBITION OF HUMAN-LEUKOCYTE ELASTASE
    DUNLAP, RP
    STONE, PJ
    ABELES, RH
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 145 (01) : 509 - 513